What ADREXpharma does

ADREXpharma GmbH is a privately held German pharmaceutical company founded in 2021 and headquartered in Koblenz, Germany. The company specializes in the development, manufacturing, and marketing of medicinal cannabis products, with a portfolio spanning cannabis flowers, THC extracts, CBD products, and Dronabinol, complemented by compounding products and a natural cosmetics line. Two sub-brands structure the cannabis offering: DrWatson (globally recognized cannabis-based solutions such as lozenges, inhalants, and oral/topical formulations, exclusively manufactured by Australia's Breathe Life Sciences) and Wildlife (strains cultivated by Canada's Wildlife Cannabis Co.). The company operates under a 'Pharma meets Cannabis' philosophy, applying pharmaceutical-grade quality controls, laboratory testing, precise dosing, and full traceability from seed to patient, with EU-GMP compliance and German regulatory licensure across wholesale (§52 AMG), narcotics handling (BtMG §3), import (§72 AMG), and manufacturing (§13 AMG).

The business model is a B2B pharmaceutical distributor-importer targeting German pharmacies and healthcare professionals, with sales enabled exclusively through German full-line wholesalers and GDP-compliant narcotics logistics partner Krieger. ADREXpharma also operates as a GMP full-service unit providing distribution and regulatory-affairs services to international producer partners. Go-to-market is sales-led via a DocCheck-protected professional portal that gives physicians and pharmacists access to product information, certificates of analysis, and batch data. Distribution is supported by a multi-country supply chain covering Australia, Canada, Colombia, and Israel through strategic partners (Breathe Life Sciences, MediPharm Labs, Pideka, BG LABS, Beacon Medical, Panaxia). Customer segments are doctors/physicians, pharmacists, and patients requiring medical cannabis therapy for indications such as pain, spasticity, and appetite enhancement. Revenue is generated through wholesale product sales and full-service distribution fees; no pricing or revenue figures are publicly disclosed.

Name

ADREXpharma

Legal name

ADREXpharma GmbH

Website

https://adrexpharma.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

11–50 employees

Short description

ADREXpharma GmbH is a privately held German pharmaceutical company founded in 2021 in Koblenz that imports, develops, and distributes medicinal cannabis products — flowers, extracts, CBD, and Dronabinol — exclusively through German full-line wholesalers and pharmacies, serving prescribers, pharmacists, and patients under EU-GMP quality standards.

Ownership category

akta.pro rank

Product category

Medicinal Cannabis Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services) (CRANAFAI)

Keywords

• Medicinal cannabis products
• Pharmaceutical cannabis distribution
• Cannabis flower products
• Dronabinol THC extracts
• CBD medical products

Headquarters

HQ city

Koblenz

HQ country

Germany

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Medicinal Cannabis Products Sales: ADREXpharma generates revenue through the sale of medicinal cannabis products including cannabis flowers, THC extracts, CBD products, and Dronabinol. Distribution occurs exclusively through German full-line wholesalers and pharmacies. The company also provides GMP full service for distribution and regulatory affairs.
2. Wholesale and Distribution Services: As a GMP full service unit, ADREXpharma is active as a service provider for all aspects of distribution and regulatory affairs, supporting partners with German market access.
3. Compounding Products: The product portfolio includes compounding products for prescription drugs such as CBD and dronabinol, sold through pharmacy channels.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

ADREXpharma develops, manufactures, and markets medicinal cannabis products — including cannabis flowers, THC extracts, CBD products, and Dronabinol — distributed exclusively through German full-line wholesalers and pharmacies. The company also operates as a GMP full service unit providing distribution and regulatory affairs services to partners in the medical cannabis value chain.

Product overview

ADREXpharma is a German pharmaceutical company specializing in medicinal cannabis products, operating a multi-spectrum product portfolio consisting of medicinal cannabis flowers, THC extracts, Cannabidiol (CBD) products, and Dronabinol. The company also offers compounding products for prescription drugs and a line of natural cosmetics. The product portfolio is distributed through two main sub-brands: DrWatson (cannabis products manufactured by Breathe Life Sciences in Australia) and Wildlife (cannabis strains from Wildlife Cannabis Co. in Canada). Products are distributed exclusively through German full-line wholesalers and pharmacies. The company also provides a protected professional portal (DocCheck) for healthcare professionals to access detailed product documentation, certificates, and ordering capabilities.

Differentiator

Problem solved

Functional benefit

Products and services

• Medical Cannabis Flowers Selectively cultivated medicinal cannabis flowers offering natural and effective therapeutic solutions for various ailments; each batch is carefully grown and harvested to ensure desired therapeutic properties. Sold to pharmacies via German full-line wholesalers for dispensing to patients.
• Cannabis Extracts (THC) High-quality concentrated THC formulations that maximize the healing properties of the cannabis plant, ideal for patients requiring precise dosing who benefit from the full range of cannabinoids and terpenes.
• Cannabidiol (CBD) Products Natural CBD products containing other cannabinoids, terpenes, and flavonoids that produce the 'entourage effect' for improved therapeutic outcomes; non-psychoactive products for gentle health support.
• Dronabinol Natural THC variant providing a proven therapeutic option for patients requiring targeted pain therapy or treatment of loss of appetite; a well-established remedy in medical cannabis therapy.
• DrWatson Product Line Globally recognized brand of medicinal cannabis products including lozenges, inhalants, oral and topical cannabis-based solutions, exclusively manufactured by Breathe Life Sciences in Australia with pharmaceutical-grade quality standards. Includes multiple strain SKUs such as Alien Mint, Rainbow Pavé AUS, Jack Flash 5 AUS, Tamarindo AUS, Tropical Blues AUS, Mimosa AUS, Rainbow Fruits AUS, White Inversion AUS, Super Boof AUS, Top Mints Cake AUS, Sub Zero AUS, Apricot Oreoz AUS, and London Gelatti AUS.
• Wildlife Cannabis Products Medicinal cannabis strains cultivated at Wildlife Cannabis Co. in Canada, including strains such as Sour Cheat Code, Animal Crackers, and Glueberry, with documented terpene profiles and effect characteristics.
• Compounding Products Customized prescription drug formulations including compounding products for specific patient needs, supplementing the standard product portfolio. Sold through pharmacy channels.
• Natural Cosmetics Line Line of natural cosmetics products as part of the holistic corporate commitment and product portfolio diversification.

Quantifiable outcome

• Products undergo strict quality controls, laboratory testing, and precise dosing
• +1 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature3 records

Partnerships

Eight partnerships are on record, tiered core and secondary.

• MediPharm LabscoreStrategic or Co-development Partner · 1 January 2025MediPharm Labs specializes in development and production of purified pharmaceutical grade cannabis concentrates, active pharmaceutical ingredients and advanced derivatives. Considered a pioneer in innovative cannabis medicines. Products include various extract formulations.
• STADAsecondaryChannel Partner/ Reseller/ Distributor · 1 March 2021German pharmaceutical company. In March 2021, ADREXpharma successfully imported and launched first shipment of cannabis flowers from Canada for STADA in Germany.
• PanaxiasecondaryStrategic or Co-development Partner · 1 February 2021Israeli medicinal cannabis manufacturer. ADREXpharma successfully launched first products from Panaxia in Germany in February 2021.
• Breathe Life Sciences (BLS)coreStrategic or Co-development PartnerBreathe Life Sciences is a wholly owned subsidiary of Australian listed company Bioxyne Ltd (BXN:ASX). BLS holds a license to manufacture medicinal cannabis, psilocybin and MDMA with full GMP certification for active ingredients and finished products. BLS is the largest producer of medicinal cannabis products in Australia and a pioneer in production of medicinal pastilles. Processes around 30 tons of cannabis flowers per year from sun, greenhouse and indoor cultivation. Has been supplying first-class medicinal cannabis from Australian cultivation to Germany via Adrex Pharma since 2025. Dr Watson brand is globally recognized, exclusively manufactured by BLS.
• PidekacoreStrategic or Co-development PartnerPideka operates a state-of-the-art indoor facility for cultivation of pharmaceutical craft cannabis near Bogota, Colombia. One of the few producers in South America with a European GMP certificate. Combines Colombian cultivation with pharmaceutical expertise, 'Hecho a mano' (handmade).
• Krieger PharmalogistikcoreImplementation/ SI/ Consulting PartnerKrieger offers specialized, GDP-compliant logistics solutions for narcotics with highest safety standards and complete traceability. Services include secure storage with access controls and video surveillance, and alarm-protected transportation. State-of-the-art technology and comprehensive certifications guarantee reliable and legally compliant handling of BtM (narcotics) products.
• Beacon MedicalsecondaryStrategic or Co-development PartnerBeacon's medicinal cannabis strains are grown in an indoor facility in Canada and are an important part of Canadian cannabis therapy. Due to international acceptance, Beacon has also become an elementary component of cannabis care in Australia with focus on economical patient care.
• BG LABScoreStrategic or Co-development PartnerBG LABS is a Colombian pharmaceutical company and member of German Boettger Group, specializing in cultivation and production of medicinal cannabis certified by German authorities according to EU-GMP. Cultivation takes place in highlands of Boyacá, Colombia with optimal altitude, sunshine and agricultural tradition. Uses sustainable cultivation methods respecting natural growth cycle and promoting biodiversity, with hand-trimming of each flower. Combines pharmaceutical excellence, quality, environmental protection and social commitment.

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

Emerging players

• MediPharm Labs: Canadian producer of pharmaceutical-grade cannabis concentrates and APIs, an existing supply partner of ADREXpharma; comparable on cannabis extract manufacturing and serves as a partial upstream peer rather than full downstream competitor.

Direct peers

• Demecan: German producer and distributor of medical cannabis flowers, extracts, and APIs with its own EU-GMP cultivation; competes head-to-head with ADREXpharma for German pharmacy channel share and prescriber relationships.
• Four 20 Pharma: German medical cannabis company importing and distributing EU-GMP flowers and extracts to German pharmacies; closely comparable product portfolio, regulatory profile, and GTM motion.
• Sanity Group: Berlin-based medical cannabis and CBD company covering cultivation, manufacturing, and pharmacy distribution in Germany; overlaps with ADREXpharma on pharmaceutical-grade positioning and pharmacy channel access.
• Cansativa: German medical cannabis distributor backed by the CanPharma network, supplying pharmacies with flowers and extracts from EU-GMP producers; directly comparable B2B pharmacy-distribution model.
• Cannamedical Pharma: Cologne-based medical cannabis importer and distributor supplying German pharmacies with EU-GMP flowers and extracts; operates a similar full-line wholesale + pharmacy model to ADREXpharma.

Broad incumbents

• Canopy Growth: Global cannabis incumbent with European medical cannabis operations including German distribution; comparable on medical cannabis product portfolio but operates a much wider portfolio across multiple categories.
• Aurora Cannabis: Major Canadian LP with established European medical cannabis distribution, including Germany; offers overlapping flowers and extracts via pharmacy channels but at parent-company scale.
• STADA Arzneimittel: Large German generics and specialty pharma that has partnered with ADREXpharma for medical cannabis imports; competes indirectly as a broader pharma and is also a potential acquisition/partnership anchor for cannabis in Germany.
• Tilray Brands: Large Canadian LP with significant EU/German medical cannabis operations across flowers, extracts, and pharma; competes for the same German pharmacy customers as ADREXpharma but at much greater scale and broader product breadth.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/adrexpharma-gmbh

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ADREXpharma